DDGP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DDGP, covering 2024-02-13 to 2024-02-13. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma [Phase 3]